Recombinant Neurospora crassa C-8 sterol isomerase (erg-1)
Product Specs
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
The tag type is determined during production. If a specific tag type is required, please inform us, and we will prioritize its development.
Target Background
KEGG: ncr:NCU04156
Q&A
What is the function of Neurospora crassa C-8 Sterol Isomerase (erg-1)?
Neurospora crassa C-8 Sterol Isomerase (erg-1) functions as a critical enzyme in the ergosterol biosynthesis pathway. It catalyzes the isomerization of the double bond between positions C-8 and C-9 to positions C-7 and C-8 of the sterol ring system. The enzyme is homologous to Erg2 of Saccharomyces cerevisiae and plays an essential role in maintaining proper sterol structure in fungal cell membranes. This isomerization step is crucial for the formation of ergosterol, which serves as the primary sterol component in fungal membranes and influences multiple cellular processes including growth, development, and membrane fusion .
How does erg-1 function in the ergosterol biosynthesis pathway?
Erg-1 occupies a specific position in the multi-step ergosterol biosynthesis pathway where it catalyzes a critical isomerization reaction. In this pathway, erg-1 acts downstream of the initial cyclization reactions that form the sterol core structure. The enzyme specifically contributes to forming the characteristic double bond arrangement in the B ring of the sterol structure. When erg-1 is absent or non-functional, the pathway becomes blocked at this isomerization step, resulting in the accumulation of sterol intermediates with altered double bond arrangements—specifically, sterols containing a double bond between positions C-8 and C-9 instead of the proper C-7 and C-8 positions found in ergosterol .
What structural features characterize the sterol intermediates in erg-1 mutants?
Gas chromatography/mass spectrometry (GC/MS) analysis has revealed that erg-1 mutants accumulate primarily three sterol intermediates with distinct structural characteristics:
| Sterol Intermediate | Double Bond Positions | Key Structural Differences from Ergosterol |
|---|---|---|
| Ergosta-8,22-dienol | C-8/C-9 and C-22/C-23 | Lacks C-5/C-6 double bond; C-8/C-9 instead of C-7/C-8 |
| Fecosterol | C-8/C-9 | Lacks C-5/C-6 double bond; C-8/C-9 instead of C-7/C-8 |
| Third intermediate* | C-8/C-9 | Double bond between C-8/C-9 instead of C-7/C-8 |
*Specific name not provided in the research data.
These structural alterations in the sterol ring system are responsible for the phenotypic abnormalities observed in erg-1 mutants, including developmental defects and impaired membrane fusion .
What phenotypic characteristics are associated with erg-1 mutations?
Mutations in erg-1 lead to several distinct phenotypic characteristics that can be observed at both macroscopic and microscopic levels:
| Phenotypic Level | Characteristics in erg-1 Mutants |
|---|---|
| Macroscopic | Characteristic pigment production; delayed growth and development |
| Microscopic | Membrane invaginations at cell-to-cell contact zones; reduced plasma membrane fusion (~50% reduction compared to wild-type) |
| Cellular | Accumulation of altered sterol intermediates; normal germling interaction frequency (81.7 ± 0.9%, comparable to wild-type) |
| Developmental | Significant delays in growth and development; mycelia exhibit specific developmental defects |
These phenotypic characteristics directly result from the altered sterol composition caused by the erg-1 mutation, highlighting the importance of proper sterol structure for normal fungal growth and development .
How do erg-1 mutations specifically impact plasma membrane fusion mechanisms?
The relationship between erg-1 mutations and plasma membrane fusion represents a fascinating area of research that reveals structure-function relationships in biological membranes. When erg-1 is deleted or mutated, plasma membrane fusion during the interaction of vegetative spore germlings becomes specifically impaired. While the frequency of initial interactions between Δerg-1 germlings remains comparable to wild-type (81.7 ± 0.9%), the fusion frequency is dramatically reduced by approximately 50% .
Microscopically, cell pairs of Δerg-1 mutants typically form characteristic membrane invaginations after physical contact, rather than successfully completing membrane merger. These invaginations represent arrested fusion intermediates that cannot progress to complete fusion. The specific structural changes in sterols—particularly the altered double bond arrangement in the B ring—appear to modify physical properties of the plasma membrane that are essential for the complex process of membrane merger .
Interestingly, knockout studies have shown that the fusion defect caused by erg-1 mutation is independent of the fusion protein PRM1, as a Δerg-1/ΔPrm1 double mutant shows an additive effect with a further 50% reduction in fusion frequency. This indicates that the altered sterol composition affects membrane fusion through mechanisms that operate in parallel to known fusion proteins. The specificity of this defect is notable since it occurs only in certain sterol biosynthesis mutants, highlighting how subtle differences in sterol structure can have significant impacts on biological processes .
How do erg-1 mutations compare with other ergosterol biosynthesis mutants?
Comparative analysis of different ergosterol biosynthesis mutants reveals distinctive patterns that provide insights into the role of specific sterol structures:
| Mutant | Accumulated Sterol(s) | Membrane Fusion Phenotype | Other Phenotypic Characteristics |
|---|---|---|---|
| Δerg-1 | Ergosta-8,22-dienol, Fecosterol, third intermediate (all with C-8/C-9 double bond) | ~50% reduction in fusion; membrane invaginations | Delayed growth; developmental defects; characteristic pigmentation |
| Δerg-10a/Δerg-10b | Ergosta-7,22-dienol (missing double bond in ring system) | ~50% reduction in fusion; membrane invaginations | Similar to Δerg-1 in appearance and pigmentation |
| Other erg mutants | Various sterol intermediates | Generally normal membrane fusion | Various developmental defects |
These comparisons highlight how specific structural features of sterols differentially impact membrane properties and protein functions, with certain sterol modifications causing highly specific cellular defects.
What experimental approaches can determine the biochemical activity of recombinant erg-1?
Determining the biochemical activity of recombinant erg-1 requires specialized approaches that address the challenges of working with membrane-associated enzymes involved in lipid modification. Several experimental strategies can be employed:
| Experimental Approach | Methodology | Key Considerations |
|---|---|---|
| In vitro isomerase assay | Incubate purified recombinant erg-1 with sterol substrates (e.g., ergosta-8,9-enol); analyze products by GC/MS or HPLC | Requires pure, active enzyme; may need detergent or lipid reconstitution systems to maintain activity |
| Complementation studies | Express recombinant erg-1 in Δerg-1 N. crassa or S. cerevisiae erg2 mutants; analyze restoration of ergosterol synthesis | Assesses functional activity in a cellular context; confirms substrate specificity |
| Chimeric protein analysis | Create chimeras between erg-1 and homologs (e.g., S. cerevisiae Erg2); test functionality in appropriate mutant backgrounds | Identifies functional domains and structure-function relationships |
| Spectroscopic analysis | Monitor spectral changes during sterol isomerization (e.g., UV absorption shifts from ~250 nm to ergosterol-specific peaks) | Can provide real-time kinetic data on isomerase activity |
A particularly informative approach involves the construction of chimeric proteins, similar to studies conducted with erg-3, where chimeras between Neurospora erg-3 and human proteins were created to test functional conservation and identify critical domains . Such chimeras between erg-1 and homologous proteins could reveal which structural elements are essential for the specific isomerase activity and substrate recognition.
How can researchers quantitatively assess erg-1's impact on membrane biophysical properties?
The impact of erg-1 on membrane biophysical properties represents a crucial aspect of understanding how sterol structure influences membrane function. Several advanced biophysical techniques can provide quantitative insights:
| Technique | Measurement | Relevance to erg-1 Research |
|---|---|---|
| Fluorescence anisotropy | Membrane fluidity and microviscosity | Determines how altered sterol structure affects membrane rigidity |
| Differential scanning calorimetry | Phase transition temperatures | Reveals how altered sterols impact membrane phase behavior |
| Atomic force microscopy | Nanomechanical properties and domain organization | Visualizes membrane topography and mechanical properties at nanoscale |
| Laurdan generalized polarization | Lipid packing and hydration | Measures changes in membrane order due to altered sterol composition |
| Giant unilamellar vesicle (GUV) assays | Membrane fusion efficiency with defined lipid compositions | Directly tests how specific sterols influence membrane fusion kinetics |
| Small-angle X-ray scattering | Membrane thickness and structural organization | Provides detailed structural information about membrane organization |
These approaches can be applied to both artificial membrane systems reconstituted with purified lipids and sterols, and to native membranes isolated from wild-type and Δerg-1 strains. Comparing the biophysical properties of membranes containing normal ergosterol versus the sterol intermediates that accumulate in Δerg-1 mutants can provide mechanistic insights into how specific structural features of sterols influence membrane properties and functions, particularly those relevant to membrane fusion .
What techniques can be used to express and purify recombinant erg-1 protein?
Expression and purification of recombinant erg-1 protein requires careful consideration of its membrane-associated nature and potential requirements for proper folding and activity. Based on available information, recombinant Neurospora crassa C-8 sterol isomerase (erg-1) has been successfully expressed with a His-tag in E. coli systems . The following protocol outlines a comprehensive approach:
| Stage | Methodology | Technical Considerations |
|---|---|---|
| Vector construction | Clone full-length erg-1 coding sequence (1-256 amino acids) into expression vector with His-tag | Codon optimization may improve expression in E. coli; consider N- or C-terminal tag placement |
| Expression system | E. coli BL21(DE3) or similar strain | Alternative systems (yeast, insect cells) may be considered if bacterial expression yields inactive protein |
| Culture conditions | LB media with appropriate antibiotic; induce at OD600 ~0.6-0.8 with IPTG (0.1-1.0 mM) | Lower induction temperature (16-25°C) may improve folding of membrane-associated proteins |
| Cell lysis | Sonication or French press in buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, protease inhibitors | Addition of mild detergents (0.5-1% Triton X-100 or 0.5% CHAPS) may improve solubilization |
| Purification | Ni-NTA affinity chromatography; elute with imidazole gradient (50-300 mM) | Consider on-column refolding if protein forms inclusion bodies |
| Secondary purification | Size exclusion chromatography to remove aggregates and improve purity | Buffer should contain stabilizing agents (glycerol, reducing agents) |
| Quality control | SDS-PAGE, Western blot, and activity assay to confirm identity and functionality | Activity assay could involve measuring conversion of sterol substrates by GC/MS |
When working with membrane-associated enzymes like erg-1, maintaining protein stability and activity throughout the purification process is particularly challenging. Incorporation of appropriate detergents or lipids in purification buffers may be essential for preserving the native conformation and enzymatic activity .
What strategies can be employed for creating and validating erg-1 knockout strains?
Creating and validating erg-1 knockout strains requires careful genetic manipulation followed by comprehensive phenotypic and molecular characterization. Based on successful generation of Δerg-1 strains reported in the literature, the following strategy can be employed:
It's important to note that erg-1 knockout strains exhibit significant growth and developmental delays, which should be considered when designing experiments and interpreting results. The characteristic phenotypes of Δerg-1, including altered pigmentation and impaired membrane fusion, provide useful markers for validating successful gene deletion .
What analytical methods best characterize sterol composition in erg-1 mutant strains?
Comprehensive characterization of sterol composition in erg-1 mutant strains requires sophisticated analytical techniques that can identify and quantify specific sterol intermediates:
For erg-1 research, GC/MS has proven most effective in characterizing the specific sterol intermediates that accumulate when the isomerization step is blocked. The distinctive double bond arrangement in these intermediates (C-8/C-9 instead of C-7/C-8) can be conclusively identified using this technique . Combined with UV spectroscopy for initial screening and potentially NMR for detailed structural confirmation, these methods provide a comprehensive toolset for sterol analysis in erg-1 mutants.
How can researchers quantitatively assess membrane fusion defects in erg-1 mutants?
Quantitative assessment of membrane fusion defects in erg-1 mutants requires a combination of microscopic and molecular approaches that can precisely measure fusion efficiency and characterize fusion intermediates:
The combination of these approaches provides multi-dimensional data on how altered sterol composition impacts specific stages of the membrane fusion process. The observation that Δerg-1 germlings establish normal contacts but exhibit reduced fusion frequency and characteristic membrane invaginations suggests that the fusion defect occurs specifically at the membrane merger stage rather than during initial recognition or contact .
What experimental designs can elucidate the relationship between sterol structure and membrane fusion?
Understanding the precise relationship between sterol structure and membrane fusion requires sophisticated experimental designs that can isolate the effects of specific structural features:
Research has already established that the structure of the sterol ring system specifically affects plasma membrane merger during the fusion of vegetative spore germlings. The double bond arrangement in the B ring appears particularly important, as both Δerg-1 and Δerg-10a/Δerg-10b mutants show similar fusion defects despite accumulating different sterol intermediates with alterations in this region .
Further experiments using the approaches outlined above could precisely define which structural features of sterols are most critical for membrane fusion and how they influence the physical properties of membranes and the function of fusion proteins.
